Hepatology

Tacrolimus was linked to lower mortality and rejection after liver transplantation, but carried a higher risk of diabetes.

Insulin resistance is independently linked to MASLD in type 1 diabetes, highlighting a distinct high-risk metabolic phenotype in affected patients.

US model study suggests a targeted hepatitis B birth-dose strategy could increase neonatal infections unless screening and vaccination remain high.

HBV reactivation risk increases after rituximab in lymphoma patients once antivirals stop, with most relapses occurring within the first year.

Alcohol intake changes influence liver disease progression, with reduced drinking linked to lower risk of liver-related events in steatotic liver disease.

Participatory medicine could reshape hepatology by involving the public, clinicians and AI to improve liver disease prevention, awareness and research engagement.

Wilson disease genetics gap is narrowing, with reanalysis and whole genome sequencing identifying previously missed ATP7B variants in most unresolved cases.

A ketogenic very low energy diet reduced liver fat by 77% in MASLD, outperforming a Mediterranean diet in a small randomised trial.